Home > National Drug Code (NDC) > Releev Cold Sore Treatment

Releev Cold Sore Treatment - 15478-001-01 - (Benzalkonium Chloride)

Alphabetical Index


Drug Information of Releev Cold Sore Treatment

Product NDC: 15478-001
Proprietary Name: Releev Cold Sore Treatment
Non Proprietary Name: Benzalkonium Chloride
Active Ingredient(s): 1.3    mg/mL & nbsp;   Benzalkonium Chloride
Administration Route(s): TOPICAL
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of Releev Cold Sore Treatment

Product NDC: 15478-001
Labeler Name: Topical Pharmaceuticals Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number: part333A
Marketing Category: OTC MONOGRAPH NOT FINAL
Start Marketing Date: 20060601

Package Information of Releev Cold Sore Treatment

Package NDC: 15478-001-01
Package Description: 1 POUCH in 1 BLISTER PACK (15478-001-01) > 1 BOTTLE, DROPPER in 1 POUCH > 1 mL in 1 BOTTLE, DROPPER

NDC Information of Releev Cold Sore Treatment

NDC Code 15478-001-01
Proprietary Name Releev Cold Sore Treatment
Package Description 1 POUCH in 1 BLISTER PACK (15478-001-01) > 1 BOTTLE, DROPPER in 1 POUCH > 1 mL in 1 BOTTLE, DROPPER
Product NDC 15478-001
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Benzalkonium Chloride
Dosage Form Name LIQUID
Route Name TOPICAL
Start Marketing Date 20060601
Marketing Category Name OTC MONOGRAPH NOT FINAL
Labeler Name Topical Pharmaceuticals Inc.
Substance Name BENZALKONIUM CHLORIDE
Strength Number 1.3
Strength Unit mg/mL
Pharmaceutical Classes

Complete Information of Releev Cold Sore Treatment


General Information